Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Mohammed S. Alasmari, Omar A. Almohammed, Alaa M. Hammad, Khalid A. Altulayhi, Bader K. Alkadi, Abdullah F. Alasmari, Faleh Alqahtani, Youssef Sari & Fawaz Alasmari. (2023) Effects of Beta Lactams on Behavioral Outcomes of Substance Use Disorders: A Meta-Analysis of Preclinical Studies. Neuroscience.
Crossref
Crossref
Majid Davidson, Niloufar Rashidi, Md Kamal Hossain, Ali Raza, Kulmira Nurgali & Vasso Apostolopoulos. (2023) Tryptophan and Substance Abuse: Mechanisms and Impact. International Journal of Molecular Sciences 24:3, pages 2737.
Crossref
Crossref
Ernest T. Chivero, Susmita Sil, Mohit Kumar & Shilpa Buch. (2022) Substance use, microbiome and psychiatric disorders. Pharmacology Biochemistry and Behavior 219, pages 173432.
Crossref
Crossref
Leonardo da Silva Neto, Angélica Faleiros da Silva Maia, Adriana Martins Godin, Paulo Sérgio de Almeida Augusto, Raissa Lima Gonçalves Pereira, Sordaini Maria Caligiorne, Rosemeire Brondi Alves, Simone Odília Antunes Fernandes, Valbert Nascimento Cardoso, Gisele Assis Castro Goulart, Felipe Terra Martins, Maila de Castro Lourenço das Neves, Frederico Duarte Garcia & Ângelo de Fátima. (2022) Calix[n]arene-based immunogens: A new non-proteic strategy for anti-cocaine vaccine. Journal of Advanced Research 38, pages 285-298.
Crossref
Crossref
Dimitri Daldegan-Bueno, Lucas O. Maia, Michelle Glass, Didier Jutras-Aswad & Benedikt Fischer. (2021) Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Psychopharmacology 239:5, pages 1211-1230.
Crossref
Crossref
Noèlia Fernàndez-Castillo, Judit Cabana-Domínguez, Roser Corominas & Bru Cormand. (2021) Molecular genetics of cocaine use disorders in humans. Molecular Psychiatry 27:1, pages 624-639.
Crossref
Crossref
Dimitri Daldegan-Bueno, Lucas O. Maia, Michelle Glass, Didier Jutras-Aswad & Benedikt Fischer. (2021) Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies. European Neuropsychopharmacology 51, pages 106-131.
Crossref
Crossref
Kelsey E. Lucerne, Aya Osman, Katherine R. Meckel & Drew D. Kiraly. (2021) Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. Neuropharmacology 192, pages 108598.
Crossref
Crossref
Laura Brandt, Thomas Chao, Sandra D. Comer & Frances R. Levin. (2020) Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction 116:4, pages 694-710.
Crossref
Crossref
Philip J. Freda, Jason H. Moore & Henry R. Kranzler. (2021) The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. Drug and Alcohol Dependence 221, pages 108602.
Crossref
Crossref
Chenyuan Qin, Jiawei Hu, Yiming Wan, Mengyao Cai, Zhenting Wang, Zhao Peng, Yuxiao Liao, Dan Li, Ping Yao, Liegang Liu, Shuang Rong, Wei Bao, Guifeng Xu & Wei Yang. (2021) Narrative review on potential role of gut microbiota in certain substance addiction. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110093.
Crossref
Crossref
Kelsey E. Lucerne & Drew D. Kiraly. 2021. Neurobiology of Addiction and Co-Morbid Disorders. Neurobiology of Addiction and Co-Morbid Disorders
311
370
.
Julia Sasiadek, Darby J.E. Lowe, Sarah-Maude Rioux & Tony P. George. 2021. Psychotic Disorders. Psychotic Disorders
107
124
.
Pedro Araos, Rebeca Vidal, Esther O’Shea, María Pedraz, Nuria García-Marchena, Antonia Serrano, Juan Suárez, Estela Castilla-Ortega, Juan Jesús Ruiz, Rafael Campos-Cloute, Luis J. Santín, Fernando Rodríguez de Fonseca, Francisco Javier Pavón & María Isabel Colado. (2019) Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients. Scientific Reports 9:1.
Crossref
Crossref
Ernest T. Chivero, Rizwan Ahmad, Annadurai Thangaraj, Palsamy Periyasamy, Balawant Kumar, Elisa Kroeger, Dan Feng, Ming-Lei Guo, Sabita Roy, Punita Dhawan, Amar B. Singh & Shilpa Buch. (2019) Cocaine Induces Inflammatory Gut Milieu by Compromising the Mucosal Barrier Integrity and Altering the Gut Microbiota Colonization. Scientific Reports 9:1.
Crossref
Crossref
Katherine R. Meckel & Drew D. Kiraly. (2019) A potential role for the gut microbiome in substance use disorders. Psychopharmacology 236:5, pages 1513-1530.
Crossref
Crossref
Maenia Scarpino, Giovanni Lanzo, Maya Salimova, Francesco Lolli, Amedeo del Vecchio, Cesarina Cossu, Maria Bastianelli, Brunella Occupati, Cecilia Lanzi, Stefano Pallanti, Aldo Amantini, Guido Mannaioni & Antonello Grippo. (2019) Efficacy of high-frequency (15 Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial. Neurophysiologie Clinique 49:1, pages 1-9.
Crossref
Crossref
Avinash De SousaAvinash De Sousa. 2019. Disulfiram. Disulfiram
31
42
.
Paul S. Regier, Kyle M. Kampman & Anna Rose Childress. 2020. Substance Use Disorders. Substance Use Disorders
299
322
.
Mitchell R. Farrell, Hannah Schoch & Stephen V. Mahler. (2018) Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms. Progress in Neuro-Psychopharmacology and Biological Psychiatry 87, pages 33-47.
Crossref
Crossref
Ryoko Susukida, Rosa M. Crum, Hwanhee Hong, Elizabeth A. Stuart & Ramin Mojtabai. (2018) Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta‐analytic studies. International Journal of Methods in Psychiatric Research 27:4.
Crossref
Crossref
Barak W. Gunter, Robert W. Gould, Michael Bubser, Kevin M. McGowan, Craig W. Lindsley & Carrie K. Jones. (2018)
Selective inhibition of M
5
muscarinic acetylcholine receptors attenuates cocaine self-administration in rats
. Addiction Biology 23:5, pages 1106-1116.
Crossref
Crossref
F. Ivy Carroll, Thomas R. Kosten, Jeffrey J. Buda, Laurene Wang & Bradford B. Walters. (2018) A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336. Frontiers in Pharmacology 9.
Crossref
Crossref
Liron Shemesh-Darvish, Doron Shinar, Hussein Hallak, Aviva Gross & Moti Rosenstock. (2018) TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene. Drug and Alcohol Dependence 188, pages 295-303.
Crossref
Crossref
Kathrine Louise Jensen, Gunnar Sørensen, Ditte Dencker, William Anthony Owens, Troels Rahbek-Clemmensen, Michael Brett Lever, Annika H. Runegaard, Nikolaj Riis Christensen, Pia Weikop, Gitta Wörtwein, Anders Fink-Jensen, Kenneth L. Madsen, Lynette Daws, Ulrik Gether & Mattias Rickhag. (2018) PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis. eneuro 5:3, pages ENEURO.0422-17.2018.
Crossref
Crossref
Kristin E. Schneider, Noa Krawczyk, Ziming Xuan & Renee M. Johnson. (2018) Past 15-year trends in lifetime cocaine use among US high school students. Drug and Alcohol Dependence 183, pages 69-72.
Crossref
Crossref
Susana Barbosa-Méndez, Maura Matus-Ortega & Alberto Salazar-Juárez. (2017) Synergistic interactions between mirtazapine and prazosin prevent the induction and expression of behavioral sensitization to cocaine in rats. Physiology & Behavior 180, pages 137-145.
Crossref
Crossref
Susana Barbosa-Méndez, Maura Matus-Ortega, Anabel Flores-Zamora, Noe Jurado & Alberto Salazar-Juárez. (2017) Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats. Psychiatry Research 254, pages 301-310.
Crossref
Crossref
Wei-Lun Sun, Pamela M. Quizon, Yaxia Yuan, Wei Zhang, Subramaniam Ananthan, Chang-Guo Zhan & Jun Zhu. (2017) Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. Scientific Reports 7:1.
Crossref
Crossref
August F. Holtyn, Todd W. Knealing, Brantley P. Jarvis, Shrindhi Subramaniam & Kenneth Silverman. (2017) Monitoring Cocaine Use and Abstinence Among Cocaine Users for Contingency Management Interventions. The Psychological Record 67:2, pages 253-259.
Crossref
Crossref
David Y.W. Lee, Jing Liu, Shuzhen Zhang, Peng Huang & Lee-Yuan Liu-Chen. (2017) Asymmetric total synthesis of tetrahydroprotoberberine derivatives and evaluation of their binding affinities at dopamine receptors. Bioorganic & Medicinal Chemistry Letters 27:6, pages 1437-1440.
Crossref
Crossref
Michael Soyka. 2017. Die Psychiatrische Notfallmedizin. Die Psychiatrische Notfallmedizin
257
290
.
M. Farr?A. Farr?J.L. P?rez de Heredia & M. Torrens. 2017. The Neuroscience of Cocaine. The Neuroscience of Cocaine
639
644
.
Tomislav Majić, Thorsten Kienast, Andreas Heinz & Michael Soyka. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1521
1570
.
Emilio S?nchez-Herv?s. (2016) Cocaine addiction: treatments and future perspectives. Trends in Psychiatry and Psychotherapy 38:4, pages 242-243.
Crossref
Crossref
Atsushi Kimishima, Cody J. Wenthur, Lisa M. Eubanks, Shun Sato & Kim D. Janda. (2016) Cocaine Vaccine Development: Evaluation of Carrier and Adjuvant Combinations That Activate Multiple Toll-Like Receptors. Molecular Pharmaceutics 13:11, pages 3884-3890.
Crossref
Crossref
M. Eugenia Socías, Evan Wood, Will Small, Huiru Dong, Jean Shoveller, Thomas Kerr, Julio Montaner & M-J Milloy. (2016) Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. Drug and Alcohol Dependence 168, pages 211-218.
Crossref
Crossref
Michael Soyka & Jochen Mutschler. (2016) Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 148-161.
Crossref
Crossref
Alessandro Papale, Ilaria Maria Morella, Marzia Tina Indrigo, Rick Eugene Bernardi, Livia Marrone, Francesca Marchisella, Andrea Brancale, Rainer Spanagel, Riccardo Brambilla & Stefania Fasano. (2016) Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors. eLife 5.
Crossref
Crossref
Joshua A. Lile, William W. Stoops, Craig R. Rush, S. Stevens Negus, Paul E.A. Glaser, Kevin W. Hatton & Lon R. Hays. (2016) Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug and Alcohol Dependence 165, pages 111-119.
Crossref
Crossref
Elias Dakwar & Edward V. Nunes. (2016) New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders. Current Psychiatry Reports 18:7.
Crossref
Crossref
M Belgers, M Leenaars, J R Homberg, M Ritskes-Hoitinga, A F A Schellekens & C R Hooijmans. (2016) Ibogaine and addiction in the animal model, a systematic review and meta-analysis. Translational Psychiatry 6:5, pages e826-e826.
Crossref
Crossref
Robert W Gould, Russell J Amato, Michael Bubser, Max E Joffe, Michael T Nedelcovych, Analisa D Thompson, Hilary H Nickols, Johannes P Yuh, Xiaoyan Zhan, Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, Frank W Byers, Jerri M Rook, John S Daniels, Colleen M Niswender, P Jeffrey Conn, Kyle A Emmitte, Craig W Lindsley & Carrie K Jones. (2015) Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects. Neuropsychopharmacology 41:4, pages 1166-1178.
Crossref
Crossref
Tomislav Majić, Thorsten Kienast, Andreas Heinz & Michael Soyka. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
51
.
Nadine Ezard, Sianne Hodge & Kate Dolan. (2015) The development and evaluation of stimulant treatment programmes. Current Opinion in Psychiatry 28:4, pages 280-285.
Crossref
Crossref